Print
Email
SaveHealthline's Premium Tools
Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
... Phase 2 clinical study of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in patients with newly diagnosed acute myeloid leukemia (AML). The first patient was enrolled by Eric Feldman , MD at the and New York Presbyterian Hospital. Dr. Feldman ...
|
|
... product manufactured by Althea will be used in the Phase I clinical study of liposomal Grb-2 in chronic myelogenous leukemia (CML), and acute myeloid leukemia (AML) which Bio-Path plans to conduct at The University of Texas M. D. Anderson Cancer ...
|
|
... product manufactured by Althea will be used in the Phase I clinical study of liposomal Grb-2 in chronic myelogenous leukemia (CML), and acute myeloid leukemia (AML) which Bio-Path plans to conduct at The University of Texas M. D. Anderson Cancer ...
|
|
For the first time, scientists have mapped out a complete cancer genome which was sequenced from a woman who has an acute myeloid leukemia tumor.
|
|
... the most common hematologic cancer in the elderly. The disease can follow an indolent course or rapidly progress to acute myelogenous leukemia (AML). Comorbidities and functional issues make this disease challenging to diagnose and treat in ...
|
|
... 2-year-old son Ian fighting rare swallowing and digestive disorders, and 9-year-old son Evan being diagnosed with leukemia in July. But good news started flowing their way this weekend -- first in the form of a bone-marrow transplant for Evan on ...
|
|
... renamed in honor of Johnny Romano , a die-hard skater and surfer who passed away in September. Johnny died of AML (Acute Myeloid Leukemia) which is a cancer of the white blood cells. His story can be read on his website and on his family's blog . ...
|
|
Washington University researchers have decoded the complete DNA of a patient suffering from Leukemia, and traced the genetic origins of her cancer.
|
|
... -- Ceplene(R) - is approved in Europe for the remission maintenance and prevention of relapse of patients with Acute Myeloid Leukemia (AML) in first remission, the most common type of leukemia in adults. In October 2008, the European Medicines ...
|
|
... or aided its progression, according to media reports Thursday. They compared the tumor tissue of a woman who died of acute myeloid leukemia (AML) to her normal tissue, and sequenced 10 mutated genes in the cancerous tissue apparently involved in ...
|
|
Scientists at Washington University in St Louis have decoded the genes of a woman who had acute myeloid leukemia and discovered a set of mutations that may have caused the cancer or aided it's progression, ...
|
|
... say the process turned up eight previously unknown genetic mutations that played a role in the patient's terminal leukemia . As it gets cheaper and easier to decode entire genomes, as opposed to just checking "usual suspect" stretches of DNA, ...
|
|
... or aided its progression, according to media reports Thursday. They compared the tumor tissue of a woman who died of acute myeloid leukemia (AML) to her normal tissue, and sequenced 10 mutated genes in the cancerous tissue apparently involved in ...
|
|
... Ley, who led the study, said the patient was a woman in her 50s who died 23 months after she was diagnosed with acute myeloid leukemia. Cancer experts said only one in five patients who get this disease, also called AML or acute myelogenous ...
|
|
Research using a new mouse model has led to the identification of a potential therapeutic target for a type of leukemia commonly associated with an unfavorable prognosis.
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.